Generic Name and Formulations:
Ferumoxsil 175mcg/mL; susp; contains parabens 1.4mg/mL.
Indications for GASTROMARK:
For oral use with magnetic resonance imaging to enhance the delineation of the bowel to distinguish it from organs and tissues that are adjacent to the upper regions of the GI tract.
Take after fasting at least 4 hours. 600mL orally at a rate of 300mL over 15 minutes. Max dose: 900mL. Optimal results occur within 30 minutes.
<16yrs: not recommended.
Known or suspected intestinal perforation or obstruction.
Current or recent hiatal hernia, esophageal reflux, nausea, vomiting, abdominal pain. Patients who cannot tolerate large fluid shifts and who are on specific fluid requirements. Inflammatory bowel disease. Disorders associated with iron overload (eg, hemosiderosis, chronic hemolytic anemia with frequent blood transfusions, chronic iron replacement). Avoid aspiration. Pregnancy (Cat.B). Nursing mothers.
Superparamagnetic iron oxide.
Diarrhea, flatulence, nausea, abdominal pain/cramps, dyspepsia, vomiting, oral paresthesia.
Neurology Advisor Articles
- 5 Key Findings Presented at 2018 Parkinson Disease Conference
- Parkinson Disease and the Gut: Treatment Potential Abounds
- Managing Comorbid Migraine and Mood Disorders: A Synergistic Approach
- Stroke-Code Patients With Low NIHSS Score, No Acute Imaging Findings Often Misdiagnosed
- Ethical Challenges of Nusinersen: Considerations When Counseling on Treatment
- Significant Variations in Epilepsy Surgical Strategy, Deficit Reporting Exist
- Smoking Promotes Disease Progression in Multiple Sclerosis
- Situation Framing, Language Can Influence Decision-Making
- Thrombolysis With Tenecteplase Is as Safe as Alteplase in Stroke Mimics
- FDA: Opioid Analgesic REMS Expanded to Include Immediate-Release Products